Overview
Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)
Status:
Completed
Completed
Trial end date:
2011-03-01
2011-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to collect and assess information on proper use of valaciclovir regarding safety and efficacy of long-term use in suppressive therapy for subjects with recurrent genital herpes.Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
GlaxoSmithKlineTreatments:
Acyclovir
Valacyclovir
Criteria
Inclusion Criteria:- Subjects who started suppressive therapy for recurrent genital herpes for the first
time
Exclusion Criteria:
- Subjects with a history of hypersensitivity to the ingredients of VALTREX or aciclovir